NULL is a dual-action cardiovascular medicine combining Rosuvastatin, a potent lipid-lowering statin, and Aspirin, a cardio-protective antiplatelet agent. It is prescribed to prevent heart attacks, strokes, and complications arising from atherosclerotic heart disease. Rosuvastatin reduces LDL cholesterol and stabilises arterial plaques, while low-dose Aspirin prevents platelet aggregation and clot formation. By addressing both plaque buildup and thrombosis, NULL offers long-term protection for individuals at high cardiovascular risk.

NULL Tablet is a fixed-dose combination designed for individuals who require continuous protection against major cardiovascular events. It is generally recommended for people with established coronary artery disease, a history of myocardial infarction, ischaemic stroke, transient ischaemic attack (TIA), or those who have undergone procedures like angioplasty or coronary stenting.

The medicine pairs two cornerstone therapies used worldwide for cardiovascular prevention:

1. Rosuvastatin, a high-potency statin that reduces LDL ("bad") cholesterol, improves endothelial function, lowers vascular inflammation, and stabilises plaques within arteries.

2. Aspirin, given in a low dose to prevent clots by inhibiting platelet aggregation.

Together, they target the two primary causes of cardiovascular events—fatty plaque progression and clot formation. This combination makes NULL a clinically relevant choice for long-term heart and brain protection, especially in individuals with additional risk factors such as diabetes, hypertension, obesity, metabolic syndrome, and smoking history.

NULL is taken once daily and forms part of ongoing cardiovascular management to prevent recurrent events, reduce disability, and promote a healthier vascular system.

Rosuvastatin 10 mg + Aspirin 75 mg

NULL is prescribed as a comprehensive cardioprotective therapy. Its primary clinical uses include:

1. Secondary Prevention of Heart Attack (Myocardial Infarction)

NULL plays a key role in reducing the risk of:

1. Recurrent heart attacks

2. Sudden cardiac death

3. Unstable angina

4. Progression of coronary artery blockages

After an acute cardiac event, arteries are vulnerable. NULL helps stabilise plaques and prevent clot formation, offering strong protection against future events.

2. Prevention of Stroke and Transient Ischaemic Attacks (TIA)

NULL helps reduce the likelihood of:

1. Ischaemic strokes

2. Mini-strokes (TIAs)

3. Stroke-related complications

By targeting both vascular inflammation and thrombosis, it provides robust cerebrovascular protection.

3. Post-Angioplasty and Stent Care

Patients undergoing angioplasty or stenting face an increased risk of clot formation. NULL helps by:

1. Lowering inflammation in blood vessels

2. Preventing clot formation inside stents

3. Reducing the risk of restenosis

It is commonly used as part of long-term therapy after coronary interventions.

4. For Individuals with High Cardiovascular Risk

NULL is beneficial for individuals who have:

1. Diabetes

2. Hypertension

3. Obesity

4. Dyslipidaemia

5. Family history of early heart disease

It significantly reduces the chances of a first heart attack or stroke.

5. Peripheral Arterial Disease (PAD)

In PAD, NULL helps by:

1. Improving blood circulation in the limbs

2. Reducing clot risk

3. Slowing the progression of artery narrowing

This may help relieve symptoms like leg pain during walking (claudication).

6. Atherosclerotic Cardiovascular Disease (ASCVD)

NULL is widely used in established ASCVD, such as:

1. Coronary artery disease

2. Carotid artery narrowing

3. Aortic or peripheral vascular plaques

It helps stabilise plaque buildup and prevents progression.

NULL delivers several clinically proven benefits:

1. Dual Protection Against Heart and Brain Events

1. Rosuvastatin reduces cholesterol and strengthens plaque stability

2. Aspirin prevents abnormal clot formation

This combined effect lowers the risk of heart attacks and strokes more effectively than either drug alone.

2. Significant Reduction in LDL Cholesterol

Rosuvastatin:

1. Substantially lowers LDL

2. Raises HDL ("good cholesterol")

3. Reduces triglycerides

4. Lowers inflammatory markers (like CRP)

Improved lipid levels translate into meaningful cardiovascular protection.

3. Prevention of Repeat Cardiovascular Events

NULL helps prevent:

1. Second heart attacks

2. Recurrent strokes

3. Stent thrombosis

4. Episodes of unstable angina

This improves long-term outcomes and reduces mortality.

4. Stabilisation of Vulnerable Plaques

Rosuvastatin:

1. Improves endothelial function

2. Decreases plaque inflammation

3. Strengthens arterial walls

This makes plaques less likely to rupture, a significant cause of sudden heart attacks.

5. Long-Term Antiplatelet Protection

Aspirin guards against:

1. Arterial clot formation

2. Blockage of narrowed vessels

3. Clots leading to stroke

Its protective effect is sustained due to irreversible platelet inhibition.

6. Reduction in Vascular Inflammation

Both components contribute to:

1. Better arterial elasticity

2. Improved microcirculation

3. Slowed atherosclerosis progression

7. Better Recovery After Cardiac Procedures

NULL supports:

1. Smoother rehabilitation

2. Reduced complications

3. Improved lipid optimisation post-procedure

8. Once-Daily Convenience

The fixed-dose combination improves:

1. Adherence

2. Convenience

3. Consistent therapeutic effect

Common Side Effects

1. Gastric discomfort

2. Acidity or heartburn

3. Mild headache

4. Muscle pain or cramps

5. Nausea

6. Changes in bowel habits

Less Common but Serious Side Effects

1. Muscle breakdown (rare statin-related effect)

2. Elevated liver enzymes

3. Bleeding tendency

4. Worsening gastritis or gastric ulcers

5. Allergic rashes or swelling

Seek Immediate Medical Help If You Notice

1. Severe muscle pain

2. Persistent or unusual bleeding

3. Dark-coloured urine

4. Yellowing of skin or eyes

1. Take one tablet daily, preferably at the same time.

2. Swallow whole with water.

3. Do not crush or chew.

4. Taking with food may reduce stomach irritation.

5. Continue long-term unless advised otherwise.

6. Do not discontinue abruptly after a cardiac event.

NULL protects the cardiovascular system through two complementary mechanisms:

1. Rosuvastatin 10 mg — Lipid Regulation

Rosuvastatin acts by:

1. Blocking HMG-CoA reductase, reducing cholesterol synthesis

2. Increasing LDL receptors on liver cells, enhancing LDL removal

3. Lowering triglycerides

4. Slightly increasing HDL

5. Reducing vascular inflammation

6. Stabilising plaques

These effects together reduce the likelihood of plaque rupture and vessel obstruction.

2. Aspirin 75 mg — Antiplatelet Action

Aspirin works by:

1. Irreversibly inhibiting the COX-1 enzyme

2. Preventing the formation of thromboxane A2

3. Stopping platelets from clumping

4. Reducing clot formation in arteries

This prevents blockage in vessels already narrowed by plaque buildup.

1. Alcohol increases gastric irritation and bleeding risk

2. High-fat diets may reduce the benefit of statins

3. Excessive citrus juice may affect statin metabolism (rare)

Inform your doctor if you take:

1. Blood thinners (warfarin, NOACs)

2. Other antiplatelets

3. Fibrates

4. High-dose niacin

5. Immunosuppressants

6. Certain antivirals

7. NSAIDs

8. Proton pump inhibitors

Use cautiously in:

1. Peptic ulcer disease

2. Bleeding disorders

3. Severe kidney impairment

4. Liver disease

5. History of muscle disorders

6. Poorly controlled blood pressure

Symptoms may include:

1. Excessive bleeding

2. Stomach irritation

3. Ringing in the ears

4. Muscle injury

5. Elevated liver enzymes

Seek emergency care immediately.

1. Take as soon as remembered

2. Skip if close to next dose

3. Do not double the dose